Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Malkowicz

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Oncogene|October 9, 1998
PTCH gene mutations in invasive transitional cell carcinoma of the bladderT W McGarvey, Y Maruta, J E Tomaszewski, et al.
Urology|May 1, 1989
Intravenous papaverine in constructing continent urinary reservoirS B Malkowicz, M R Avon, D Thangathurai, et al.
Radiology|November 10, 1998
Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomyT A Manzone, S B Malkowicz, J E Tomaszewski, et al.
International Journal of Impotence Research|January 19, 2000
Retrospective review of flow patterns following retropubic prostatectomyD S Blander, G A Broderick, S B Malkowicz, et al.
The Journal of Urology|September 25, 1997
Outcome based staging for clinically localized adenocarcinoma of the prostateA V D'Amico, R Whittington, D Schultz, et al.
The Journal of Surgical Research|December 1, 1995
Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cellsN Sion-Vardy, D Vardy, U Rodeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trialA V D'Amico, R Whittington, S B Malkowicz, et al.
The Journal of Urology|September 1, 1990
The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)S B Malkowicz, P Nichols, G Lieskovsky, et al.
Journal of the National Cancer Institute|August 27, 1998
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4T R Rebbeck, J M Jaffe, A H Walker, et al.
Cancer|May 17, 2000
Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7A V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Oncogene|October 9, 1998
PTCH gene mutations in invasive transitional cell carcinoma of the bladderT W McGarvey, Y Maruta, J E Tomaszewski, et al.
Urology|May 1, 1989
Intravenous papaverine in constructing continent urinary reservoirS B Malkowicz, M R Avon, D Thangathurai, et al.
Radiology|November 10, 1998
Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomyT A Manzone, S B Malkowicz, J E Tomaszewski, et al.
International Journal of Impotence Research|January 19, 2000
Retrospective review of flow patterns following retropubic prostatectomyD S Blander, G A Broderick, S B Malkowicz, et al.
The Journal of Urology|September 25, 1997
Outcome based staging for clinically localized adenocarcinoma of the prostateA V D'Amico, R Whittington, D Schultz, et al.
The Journal of Surgical Research|December 1, 1995
Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cellsN Sion-Vardy, D Vardy, U Rodeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trialA V D'Amico, R Whittington, S B Malkowicz, et al.
The Journal of Urology|September 1, 1990
The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)S B Malkowicz, P Nichols, G Lieskovsky, et al.
Journal of the National Cancer Institute|August 27, 1998
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4T R Rebbeck, J M Jaffe, A H Walker, et al.
Cancer|May 17, 2000
Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7A V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 12